Product Description
Since last many years Saintroy Lifescience is leading manufacture,export and supplier of Voglibose and Metformin HCL tablets from Surat, Gujarat, India. Voglibose and Metformin HCL tablets used for lowering post-prandial blood glucose levels in people with diabetes mellitus. Voglibose delays the absorption of glucose there by reducing the risk of macro vascular complications.
Tags: Voglibose and Metformin HCL tablets manufacturer Vogliboseand Metformin HCL tablets exporter, Voglibose and Metformin HCL tablets supplier, Voglibose and Metformin HCL tablets Voglibose and Metformin HCL tablets, whogmp approved Voglibose and Metformin HCL tablets manufacturer and supplier, Voglibose and Metformin HCL tablets distributor, Vogliboseand Metformin HCL tablets dropshipper, Voglibose and Metformin HCL tablets , Voglibose and Metformin HCL tablets supplier, Voglibose and Metformin HCL tablets.
ISO/GMP/c-GMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility in Gujarat, India.
Registration: Saintroy Lifescience is interested in registration of own brand or customer brands in ministry of health of clients country and we also provide the products samples,COA, COPP, ACTD or CTD Dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country :Saintroy Lifescience Voglibose and Metformin HCL Tablets export to USA,Canada, Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal, Sudan, UAE,Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile, Somalia, Philippines, Myanmar,Maldives, Thailand, Singapore, Malaysia, Hong Kong, China, Zimbabwe, Togo,Burkina Faso, Niger, Guinea Bissau, Congo, Democratic of republic, Ivory Costa,Oman, Guatemala, Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba,Colombia, Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran,Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Dual Action Diabetes ControlVoglibose and Metformin HCL tablets combine two effective ingredients to help regulate blood glucose levels in type 2 diabetes patients. Together, they provide comprehensive control, making them an ideal option for managing diabetes across various age groups including teenagers, women, and older adults.
Safe and Convenient UsageDesigned for ease of use, these tablets are offered in a physical tablet form, making daily administration straightforward. They are formulated for safe consumption and distributed across India by reliable dealers, manufacturers, and suppliers.
FAQ's of Voglibose and Metformin HCL tablets:
Q: How should Voglibose and Metformin HCL tablets be administered?
A: These tablets should be taken exactly as prescribed by your physician. The typical dosage and frequency depend on individual health conditions, so follow your doctor's instructions for best results.
Q: What are the main benefits of using Voglibose and Metformin HCL tablets?
A: The main benefits include improved blood sugar control and reduced risk of diabetes-related complications. The combination addresses glucose absorption and production effectively for people with type 2 diabetes.
Q: When is the best time to take these tablets?
A: It is recommended to take these tablets at the same time daily, usually with meals, unless otherwise directed by your physician to reduce gastrointestinal discomfort.
Q: Who can use Voglibose and Metformin HCL tablets?
A: These tablets are suitable for women, teenagers, and aged persons diagnosed with type 2 diabetes. However, they must only be used under medical supervision.
Q: What is the recommended process for sourcing these tablets in India?
A: You can obtain Voglibose and Metformin HCL tablets from authorized dealers, distributors, exporters, manufacturers, suppliers, and wholesalers throughout India.
Q: Where should I store Voglibose and Metformin HCL tablets?
A: Store the tablets in a cool and dry place, away from direct sunlight and moisture, to preserve their potency and safety.
Q: What precautions should be followed while using these tablets?
A: Always follow dosage guidelines as directed by your physician and keep the tablets out of reach of children. Do not change your dose or stop using the medication without consulting your healthcare provider.